ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Gilead signs drug discovery deal with Second Genome pharmaceutical-technology
April 08, 2020Gilead Sciences has entered a multi-programme agreement with Second Genome to discover targets and drug candidates for inflammatory bowel disease (IBD) treatment. -
Second Genome Doses First Patient in SGM-1019 Study americanpharmaceuticalreview
January 24, 2019Second Genome announced the first patient has been dosed in a Phase 2 clinical trial evaluating SGM-1019 for the treatment of nonalcoholic steatohepatitis (NASH). SGM-1019 is a first-in-class....
Pharma Sources Insight July 2025
